Skip to main content

STING/IFN Activation Promotes ANCA-Associated Vasculitis Progression

Aug 29, 2022 4:56 pm

Research presented in the Journal of Experimental Medicine shows that ANCA-associated vasculitis (AAV) may be propagated by pathogenic mechanisms triggering cGAS/STING/IRF3-dependent IFN-I release.

The studied 31 patients with ANCA vasculitis and 57 healthy controls while also developing a novel mouse model that develops pulmonary AAV (mimicking severe disease in patients).

Disease was induced by immunogenic DNA during disease onset, leading to activation of cGAS/STING/IRF3-dependent IFN-I release with subsequent endothelial damage, pulmonary hemorrhages, and lung dysfunction.

They found that while monocyte-derived macrophages were major disease drivers by producing most IFN-β, resident alveolar macrophages were involved in tissue clean up and limiting infiltration of IFN-β–producing macrophages.

They showed that pharmacological inhibition of STING, IFNAR-I, or its downstream JAK/STAT signaling with baricitinib reduced disease severity and accelerated recovery.

Our findings suggest an important pathogenic role for the STING/IFN-I axis in promoting pulmonary AAV progression and identifies a potential therapeutic targets to to treat AAV. 


If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

The author has no conflicts of interest to disclose related to this subject